Effects of Chronic Administration of P-Cymene in an Animal Model of LPS-Induced Autism

Abstract

p-Cymene is a monoterpene found in over 100 plant species. It shows a range of biological activity, including anti-inflammatory and antimicrobial effects. It is possibly a new therapeutic alternative for autism spectrum disorder characterized by deficits in interaction and behavioral abnormalities. These symptoms can occur in response to maternal immune activation through prenatal exposure to lipopolysaccharide. Thus, this study aimed to evaluate the behavioral, memory, and biochemical effects of chronic administration of p-cymene in an animal model of autism by prenatal maternal exposure to lipopolysaccharide. Twenty-four pregnant Wistar rats were used, who received 100 μg/kg of lipopolysaccharide or saline intraperitoneally (i.p.) on the 9.5 gestational day. After birth, the male offspring remained with the mothers until weaning and underwent model validation tests on postnatal day 30. From postnatal day 31 on, chronic administration, via i.p., of saline (1 mL/kg), risperidone (0.2 mg/kg), or p-cymene (100 mg/kg) for 22 days was performed. The animals were submitted to behavioral (postnatal day 52) and memory tests (postnatal days 52–53) and subsequently sacrificed (postnatal day 54) when their brain structures were removed for quantification of proinflammatory cytokines (TNF-α, interleukin 1β, and interleukin 6). Prenatal exposure to lipopolysaccharide significantly increased episodes of stereotyped movement (p=0.0001) and decreased parameters of social interaction in offspring, including sniffing, following, mounting, and allowing mounting (p=0.0043, p<0.0001, p=0.0009, and p=0.0200, respectively). Chronic p-cymene treatment was not significant for behavioral, memory, and biochemical tests. However, due to their pharmacokinetic characteristics, p-cymene nanomaterials’ formulation may be an exciting alternative to be tested for further results.

Key words

p-cymene - maternal immune activation - autism spectrum disorder - lipopolysaccharides - proinflammatory cytokines

Publication History

Received: 18 November 2020
Received: 30 March 2021

Accepted: 23 April 2021

Article published online:
11 August 2021

• References

• 1 Santana MF, Quintans-Júnior LJ, Cavalcanti SCH, Oliveira MGB, Guimarães AG, Cunha ES. et al. p-Cymene reduces orofacial nociceptive response in mice. Brazilian J Pharmacogn 2011; 21: 1138-1143
• 2 Games E, Guerreiro M, Santana FR, Pinheiro NM, de Oliveira EA, Lopes FDTQS. et al. Structurally Related Monoterpenes p-Cymene, Carvacrol and Thymol Isolated from Essential Oil from Leaves of Lippia sidoides Cham. (Verbenaceae) Protect Mice against Elastase-Induced Emphysema. Molecules 2016; 21: 1-17
• 3 Siani AC, Ribeiro-dos-santos R, Fernadez-ferreira E, Rosas EC, Susunaga GS, Guimara AC. Evaluation of anti-in ammatory-related activity of essential oils from the leaves and resin of species of. Control 1999; 66: 57-69
• 4 Benchaar C, Calsamiglia S, Chaves AV, Fraser GR, Colombatto D, McAllister TA, Beauchemin KA. A review of plant-derived essential oils in ruminant nutrition and production. Anim Feed Sci Technol 2008; 145: 209-228
• 5 Philis JG. The S1 ← S0 spectrum of jet-cooled p-cymene. Spectrochim Acta A Mol Biomol Spectrosc 2005; 61: 1239-1241
• 6 Quintans JSS, Menezes PP, Santos MRV, Bonjardim LR, Almeida JRGS, Gelain DP. et al. Improvement of p-cymene antinociceptive and anti-inflammatory effects by inclusion in β-cyclodextrin. Phytomedicine 2013; 20: 436-440
• 7 Bonjardim LR, Cunha ES, Guimarães AG, Santana MF, Oliveira MGB, Serafini MM. et al. Evaluation of the anti-inflammatory and antinociceptive properties of p-cymene in mice. Z Naturforsch C J Biosci 2012; 67: 15-21
• 8 Rattanachaikunsopon P, Phumkhachorn P. Synergistic antimicrobial effect of nisin and p-cymene on Salmonella enterica serovar typhi in vitro and on ready-to-eat food. Biosci Biotechnol Biochem 2010; 74: 520-524
• 9 American Psychiatric Association. DSM-5 Update. Diagnostic and Statistical Manual of Mental Disorders 2017; 1-42
• 10 Rubenstein E, Wiggins LD, Schieve LA, Bradley C, DiGuiseppi C, Moody E. et al. Associations between parental broader autism phenotype and child autism spectrum disorder phenotype in the Study to Explore Early Development. Autism 2019; 23: 436-448
• 11 Ramaswami G, Geschwind DH. Genetics of autism Spectrum Disorder. 1. Aufl. Elsevier B.V; 2018
• 12 Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Water JV. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011; 25: 40-45
• 13 Careaga M, Van de Water J, Ashwood P. Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 2010; 7: 283-292
• 14 Theoharides TC, Stewart JM, Panagiotidou S, Melamed I. Mast cells, brain inflammation and autism. Eur J Pharmacol 2016; 778: 96-102
• 15 Bilbo SD, Block CL, Bolton JL, Hanamsagar R, Tran PK. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol 2018; 299: 241-251
• 16 Bilbo SD, Schwarz JM. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 2009; 3: 1-14
• 17 Knuesel I, Chicha L, Britschgi M, Schobel AS, Bodmer M, Hellings JA. et al. Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol 2014; 10: 643-660
• 18 Estes ML, McAllister AK. Maternal immune activation: Implications for neuropsychiatric disorders. Science 2016; 353: 772-777
• 19 Kirsten TB, Bernardi MM. Prenatal lipopolysaccharide induces hypothalamic dopaminergic hypoactivity and autistic-like behaviors: Repetitive self-grooming and stereotypies. Behav Brain Res 2017; 331: 25-29
• 20 Lombardo MV, Moon HM, Su J, Palmer TD, Courchesne E, Pramparo T. Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder. Mol Psychiatry 2017; 1-13
• 21 Choi GB, Yim YS, Wong H, Kim S, Kim H, Kim SV. et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 2016; 351: 933-939
• 22 Allam AA, Abo-Eleneen RE. The development of sensorimotor reflexes in albino mice; albino rats and black-hooded rats. Int J Dev Neurosci 2012; 30: 545-553
• 23 Hancock GIP, Stokes MA, Mesibov GB. Socio-sexual functioning in autism spectrum disorder: A systematic review and meta-analyses of existing literature. Autism Res 2017; 1-11
• 24 Spencer SJ, Mouihate A, Galic MA, Ellis SL, Pittman QJ. Neonatal immune challenge does not affect body weight regulation in rats. Am J Physiol Regul Integr Comp Physiol 2007; 293: R581-R589
• 25 Anagnostou E. Clinical trials in autism spectrum disorder: evidence, challenges and future directions. Curr Opin Neurol 2018; 31: 119-125
• 26 Kalueff AV, Wayne Aldridge J, Laporte JL, Murphy DL, Tuohimaa P. Analyzing grooming microstructure in neurobehavioral experiments. Nat Protoc 2007; 2: 2538-2544
• 27 Roullet FI, Crawley JN. Mouse models of autism: testing hypotheses about molecular mechanisms. Curr Top Behav Neurosci 2011; 7: 187-212
• 28 Fortunato JJ, Rosa N, Laurentino AOM, Goulart M, Michalak C, Borges LP. et al. Effects of omega-3 fatty acids on stereotypical behavior and social interactions in Wistar rats prenatally exposed to lipopolysaccarides. Nutrition 2017; 35: 119-127
• 29 Atladóttir HÓ, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M. et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010; 40: 1423-1430
• 30 Pasciuto E, Borrie SC, Kanellopoulos AK, Santos AR, Cappuyns E, D’Andrea L. et al. Autism Spectrum Disorders: Translating human deficits into mouse behavior. Neurobiol Learn Mem 2015; 124: 71-87
• 31 Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003; 463: 3-33
• 32 Murai T, Okuda S, Tanaka T, Ohta H. Characteristics of object location memory in mice: Behavioral and pharmacological studies. Physiol Behav 2007; 90: 116-124
• 33 Cohen SJ, Stackman RW. Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav Brain Res 2015; 285: 105-117
• 34 Czerniawski J, Guzowski JF. Acute neuroinflammation impairs context discrimination memory and disrupts pattern separation processes in hippocampus. J Neurosci 2014; 34: 12470-12480
• 35 Theoharides TC, Asadi S, Patel AB. Focal brain inflammation and autism. J Neuroinflammation 2013; 10: 815
• 36 Wong H, Hoeffer C. Maternal IL-17A in autism. Exp Neurol 2018; 299: 228-240
• 37 Arora M, Reichenberg A, Willfors C, Austin C, Gennings C, Berggren S. et al. Fetal and postnatal metal dysregulation in autism. Nat Commun 2017; 8: 1-10
• 38 McNamara RK, Jandacek R, Rider T, Tso P. Chronic risperidone normalizes elevated pro-inflammatory cytokine and C-reactive protein production in omega-3 fatty acid deficient rats. Eur J Pharmacol 2011; 652: 152-156
• 39 Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY. et al. In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res 1997; 26: 221-225
• 40 Song X, Fan X, Li X, Zhang W, Gao J, Zhao J. et al. Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia. Psychopharmacology (Berl) 2014; 231: 319-325
• 41 Al-Amin MM, Uddin MMN, Reza HM. Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci 2013; 11: 144-151
• 42 Chen ML, Tsai TC, Wang LK, Lin YY, Tsai YM, Lee MC. et al. Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-α-directed cell apoptosis in neutrophils. Int Immunopharmacol 2012; 12: 197-204
• 43 Xie G, Chen N, Soromou LW, Liu F, Xiong Y, Wu O. et al. p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation. Molecules 2012; 17: 8159-8173
• 44 Zhong W, Chi G, Jiang L, Soromou LW, Chen N, Huo M. et al. p-Cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation. Inflammation 2013; 36: 529-537
• 45 Silva MTM, Ribeiro FPRA, Medeiros MAMB, Sampaio PA, Silva YMS, Silva MTA. et al. The vasorelaxant effect of p-cymene in rat aorta involves potassium channels. ScientificWorld Journal 2015; 2015: 458080
• 46 Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 1983; 305: 147-148
• 47 Miller C. An overview of the potassium channel family. Genome Biol 2000; 1 doi:
• 48 Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 2002; 61: 337-362
• 49 Serafini MR, Menezes PP, Costa LP, Lima CM, Quintans LJ, Cardoso JC. et al. Interaction of p-cymene with β-cyclodextrin. J Therm Anal Calorim 2012; 951-955
• 50 Hu X, Chu Y, Ma G, Li W, Wang X, Mo H. et al. Simultaneous determination of ascaridole, p-cymene and α-terpinene in rat plasma after oral administration of Chenopodium ambrosioides L. by GC-MS. Biomed Chromatogr 2015; 29: 1682-1686
• 51 Walde A, Ve B, Scheline RR, Monge P. p-Cymene metabolism in rats and guinea-pigs. Xenobiotica 1983; 13: 503-512
• 52 Southwell IA, Flynn TM, Degabriele R. Metabolism of alpha- and beta-pinene, p-cymene and 1,8-cineole in the brushtail possum, Trichosurus vulpecula. Xenobiotica 1980; 10: 17-23
• 53 Maciel RAP, Rempel LCT, Bosquetti B, Finco AB, Pecoits-Filho R, Souza WM. et al. p-cresol but not p-cresyl sulfate stimulate MCP-1 production via NF-κB p65 in human vascular smooth muscle cells. J Bras Nefrol 2016; 38: 153-160
• 54 Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther 2012; 30: 49-59
• 55 Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J. et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 2010; 68: 368-376
• 56 Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012; 26: 383-392
• 57 Donsì F, Annunziata M, Sessa M, Ferrari G. Nanoencapsulation of essential oils to enhance their antimicrobial activity in foods. LWT - Food Sci Technol 2011; 44: 1908-1914
• 58 Bambini-Junior V, Rodrigues L, Behr GA, Moreira JCF, Riesgo R, Gottfried C. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Brain Res 2011; 1408: 8-16
• 59 Spencer SJ, Mouihate A, Galic MA, Elis SL, Pittman QJ. Neonatal immune challenge does not affect body weight regulation in rats. AJP Regul Integr Comp Physiol 2007; 293: R581-R589
• 60 Battisti JJ, Shreffler CB, Uretsky NJ, Wallace LJ. NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy. Pharmacol Biochem Behav 2000; 67: 241-246
• 61 Schneider T, Przewłocki R. Behavioral alterations in rats prenatally to valproic acid: animal model of autism. Neuropsychopharmacology 2005; 30: 80-89
• 62 Dere E, Huston JP, De Souza Silva MA. Integrated memory for objects, places, and temporal order: evidence for episodic-like memory in mice. Neurobiol Learn Mem 2005; 84: 214-221
• 63 Walker JM, Kruger NJ. The Bradford method for protein quantitation. Basic Protein Pept Protoc 2003; 32: 9-16